{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:33:03Z","timestamp":1761129183929},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T00:00:00Z","timestamp":1407974400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2458-14-845","type":"journal-article","created":{"date-parts":[[2014,8,14]],"date-time":"2014-08-14T01:07:09Z","timestamp":1407978429000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling"],"prefix":"10.1186","volume":"14","author":[{"given":"Ruth","family":"Zimmermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Sch\u00e4ffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Leicht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Wenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stine","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Santos-H\u00f6vener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Stefan","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oumaima","family":"Stambouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boris-Alexander","family":"Ratsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Bannert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus-Thomas","family":"Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"K\u00fccherer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamah","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,14]]},"reference":[{"key":"7288_CR1","volume-title":"Hepatitis B - Fact sheet N\u00b0204","author":"World Health Organization","year":"2013","unstructured":"World Health Organization: Hepatitis B - Fact sheet N\u00b0204. 2013, Geneva: WHO, [ http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en\/ ]"},{"issue":"9791","key":"7288_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","volume":"378","author":"PK Nelson","year":"2011","unstructured":"Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L: Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011, 378 (9791): 571-583. 10.1016\/S0140-6736(11)61097-0.","journal-title":"Lancet"},{"issue":"5\u20136","key":"7288_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00103-013-1673-x","volume":"56","author":"C Poethko-Muller","year":"2013","unstructured":"Poethko-Muller C, Zimmermann R, Hamouda O, Faber M, Stark K, Ross RS, Thamm M: Epidemiology of hepatitis A, B, and C among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2013, 56 (5\u20136): 707-715.","journal-title":"Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz"},{"issue":"6","key":"7288_CR4","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/ije\/26.6.1359","volume":"26","author":"K Stark","year":"1997","unstructured":"Stark K, Bienzle U, Vonk R, Guggenmoos-Holzmann I: History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin. Int J Epidemiol. 1997, 26 (6): 1359-1366. 10.1093\/ije\/26.6.1359.","journal-title":"Int J Epidemiol"},{"issue":"3 Suppl 1","key":"7288_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-2002-32760","volume":"2002","author":"J Brack","year":"2002","unstructured":"Brack J: Die Hepatitiden B und C bei drogenabh\u00e4ngigen Patienten: Eine epidemiologische Studie. Suchttherapie. 2002, 2002 (3 Suppl 1): 3-10.","journal-title":"Suchttherapie"},{"issue":"3","key":"7288_CR6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/hep.21347","volume":"44","author":"R Williams","year":"2006","unstructured":"Williams R: Global challenges in liver disease. Hepatology. 2006, 44 (3): 521-526. 10.1002\/hep.21347.","journal-title":"Hepatology"},{"issue":"9","key":"7288_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","volume":"5","author":"CW Shepard","year":"2005","unstructured":"Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005, 5 (9): 558-567. 10.1016\/S1473-3099(05)70216-4.","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"7288_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1086\/513727","volume":"28","author":"S Kamili","year":"2007","unstructured":"Kamili S, Krawczynski K, McCaustland K, Li X, Alter MJ: Infectivity of hepatitis C virus in plasma after drying and storing at room temperature. Infect Control Hosp Epidemiol. 2007, 28 (5): 519-524. 10.1086\/513727.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"2","key":"7288_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/infdis\/jis677","volume":"207","author":"J Doerrbecker","year":"2013","unstructured":"Doerrbecker J, Behrendt P, Mateu-Gelabert P, Ciesek S, Riebesehl N, Wilhelm C, Steinmann J, Pietschmann T, Steinmann E: Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment. J Infect Dis. 2013, 207 (2): 281-287. 10.1093\/infdis\/jis677.","journal-title":"J Infect Dis"},{"issue":"12","key":"7288_CR10","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/infdis\/jir535","volume":"204","author":"J Doerrbecker","year":"2011","unstructured":"Doerrbecker J, Friesland M, Ciesek S, Erichsen TJ, Mateu-Gelabert P, Steinmann J, Steinmann J, Pietschmann T, Steinmann E: Inactivation and survival of hepatitis C virus on inanimate surfaces. J Infect Dis. 2011, 204 (12): 1830-1838. 10.1093\/infdis\/jir535.","journal-title":"J Infect Dis"},{"issue":"7","key":"7288_CR11","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1086\/656212","volume":"202","author":"E Paintsil","year":"2010","unstructured":"Paintsil E, He H, Peters C, Lindenbach BD, Heimer R: Survival of hepatitis C virus in syringes: implication for transmission among injection drug users. J Infect Dis. 2010, 202 (7): 984-990. 10.1086\/656212.","journal-title":"J Infect Dis"},{"issue":"1","key":"7288_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1440-1746.2006.04358.x","volume":"22","author":"J Reimer","year":"2007","unstructured":"Reimer J, Lorenzen J, Baetz B, Fischer B, Rehm J, Haasen C, Backmund M: Multiple viral hepatitis in injection drug users and associated risk factors. J Gastroenterol Hepatol. 2007, 22 (1): 80-85. 10.1111\/j.1440-1746.2006.04358.x.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"7288_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1023\/A:1024603517136","volume":"18","author":"M Backmund","year":"2003","unstructured":"Backmund M, Meyer K, W\u00e4chtler M, Eichenlaub D: Hepatitis C virus infection in injection drug users in Bavaria: risk factors for seropositivity. Eur J Epidemiol. 2003, 18 (6): 563-568.","journal-title":"Eur J Epidemiol"},{"key":"7288_CR14","volume-title":"Abschlussbericht: Szenebefragung in Deutschland 2008","author":"K Thane","year":"2009","unstructured":"Thane K, Wickert C, Verthein U: Abschlussbericht: Szenebefragung in Deutschland 2008. 2009, Hamburg: Institut f\u00fcr interdisziplin\u00e4re Suchtforschung,- ISD"},{"key":"7288_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1017\/S0950268802007902","volume":"129","author":"K Roy","year":"2002","unstructured":"Roy K, Hay G, Andragetti R, Taylor A, Goldberg D, Wiessing L: Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol Infect. 2002, 129: 577-585. 10.1017\/S0950268802007902.","journal-title":"Epidemiol Infect"},{"issue":"48","key":"7288_CR16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2807\/ese.16.48.20031-en","volume":"16","author":"L Wiessing","year":"2011","unstructured":"Wiessing L, Likatavicius G, Hedrich D, Guarita B, van de Laar MJ, Vicente J: Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010. Eurosurveillance. 2011, 16 (48): 9-13.","journal-title":"Eurosurveillance"},{"issue":"4","key":"7288_CR17","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3109\/00365549509032726","volume":"27","author":"K Stark","year":"1995","unstructured":"Stark K, Schreier E, M\u00fcller R, Wirth D, Driesel G, Bienzle U: Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis. 1995, 27 (4): 331-337. 10.3109\/00365549509032726.","journal-title":"Scand J Infect Dis"},{"key":"7288_CR18","first-page":"273","volume":"30","author":"Robert Koch-Institut (RKI)","year":"2013","unstructured":"Robert Koch-Institut (RKI): Zur Situation bei wichtigen Infektionskrankheiten in Deutschland: Virushepatitis C im Jahr 2012. Epid Bull. 2013, 30: 273-284.","journal-title":"Epid Bull"},{"issue":"1","key":"7288_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-2334-9-113","volume":"9","author":"M Jauffret-Roustide","year":"2009","unstructured":"Jauffret-Roustide M, Le Strat Y, Couturier E, Thierry D, Rondy M, Quaglia M, Razafandratsima N, Emmanuelli J, Guibert G, Barin F: A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design. BMC Infect Dis. 2009, 9 (1): 113-10.1186\/1471-2334-9-113.","journal-title":"BMC Infect Dis"},{"issue":"4","key":"7288_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1111\/j.1365-2893.2010.01297.x","volume":"18","author":"VD Hope","year":"2011","unstructured":"Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, Ncube F, Parry JV: Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat. 2011, 18 (4): 262-270. 10.1111\/j.1365-2893.2010.01297.x.","journal-title":"J Viral Hepat"},{"issue":"1","key":"7288_CR21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5694\/j.1326-5377.1997.tb138757.x","volume":"167","author":"N Crofts","year":"1997","unstructured":"Crofts N, Aitken CK: Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria in 1990\u20131995. Med J Aust. 1997, 167 (1): 17-20.","journal-title":"Med J Aust"},{"issue":"10","key":"7288_CR22","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/j.1360-0443.2006.01543.x","volume":"101","author":"L Maher","year":"2006","unstructured":"Maher L, Jalaludin B, Chant KG, Jayasuriya R, Sladden T, Kaldor JM, Sargent PL: Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction. 2006, 101 (10): 1499-1508. 10.1111\/j.1360-0443.2006.01543.x.","journal-title":"Addiction"},{"key":"7288_CR23","volume-title":"UNAIDS Report on the Global AIDS Epidemic 2013","author":"Joint United Nations Programme on HIV\/AIDS (UNAIDS)","year":"2013","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS): UNAIDS Report on the Global AIDS Epidemic 2013. 2013, Geneva: UNAIDS, [ http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/epidemiology\/2013\/gr2013\/UNAIDS_Global_Report_2013_en.pdf ]"},{"key":"7288_CR24","volume-title":"HIV\/AIDS Surveillance in Europe 2010","author":"European Centre for Disease Prevention and Control, WHO Regional Office for Europe","year":"2011","unstructured":"European Centre for Disease Prevention and Control, WHO Regional Office for Europe: HIV\/AIDS Surveillance in Europe 2010. 2011, Stockholm: European Centre for Disease Prevention and Control (ECDC)"},{"key":"7288_CR25","first-page":"1","volume":"45","author":"Robert Koch-Institut","year":"2013","unstructured":"Robert Koch-Institut: Weiterf\u00fchrende Analysen zur HIV-Inzidenz- und -Pr\u00e4valenzsch\u00e4tzung 2012. Epidemiologisches Bulletin-Robert Koch Institut. 2013, 45: 1-12.","journal-title":"Epidemiologisches Bulletin-Robert Koch Institut"},{"issue":"39","key":"7288_CR26","doi-asserted-by":"publisher","first-page":"6058","DOI":"10.1038\/sj.onc.1208968","volume":"24","author":"FA Proietti","year":"2005","unstructured":"Proietti FA, Carneiro-Proietti ABF, Catalan-Soares BC, Murphy EL: Global epidemiology of HTLV-I infection and associated diseases. Oncogene. 2005, 24 (39): 6058-6068. 10.1038\/sj.onc.1208968.","journal-title":"Oncogene"},{"issue":"2","key":"7288_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1423-0410.2008.01136.x","volume":"96","author":"S Laperche","year":"2009","unstructured":"Laperche S, Worms B, Pillonel J: Blood safety strategies for human T-cell lymphotropic virus in Europe. Vox Sang. 2009, 96 (2): 104-110. 10.1111\/j.1423-0410.2008.01136.x.","journal-title":"Vox Sang"},{"issue":"3","key":"7288_CR28","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jcv.2005.06.006","volume":"35","author":"L de la Fuente","year":"2006","unstructured":"de la Fuente L, Toro C, Soriano V, Brugal MT, Vallejo F, Barrio G, Jimenez V, Silva T, Project Itinere Working Group: HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates. J Clin Virol. 2006, 35 (3): 244-249. 10.1016\/j.jcv.2005.06.006.","journal-title":"J Clin Virol"},{"issue":"5","key":"7288_CR29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1089\/aid.2010.0263","volume":"27","author":"M Abad","year":"2011","unstructured":"Abad M, Dronda F, Dominguez E, Moreno S, Vallejo A: HTLV-2b among HIV type 1-coinfected injecting drug users in Spain. AIDS Res Hum Retroviruses. 2011, 27 (5): 579-583.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"8","key":"7288_CR30","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1089\/088922299310782","volume":"15","author":"JF Egan","year":"1999","unstructured":"Egan JF, O\u2019Leary B, Lewis MJ, Mulcahy F, Sheehy N, Hasegawa H, Fitzpatrick F, O\u2019Connor JJ, O\u2019Riordan J, Hall WW: High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland. AIDS Res Hum Retroviruses. 1999, 15 (8): 699-705. 10.1089\/088922299310782.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"4","key":"7288_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/aid.2005.21.249","volume":"21","author":"AF Silva","year":"2005","unstructured":"Silva AF, Almeida C, Martins HC, Coutinho R, Leitao E, Silva R, Paixao MT, Padua E: Prevalence and molecular characterization of human T cell leukemia virus type 2 in a group of intravenous drug users coinfected with HIV type 1 in Portugal. AIDS Res Hum Retroviruses. 2005, 21 (4): 249-255. 10.1089\/aid.2005.21.249.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"11","key":"7288_CR32","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3109\/00365548.2012.689847","volume":"44","author":"K Malm","year":"2012","unstructured":"Malm K, Ekermo B, Hillgren K, Britton S, Fredlund H, Andersson S: Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden. Scand J Infect Dis. 2012, 44 (11): 852-859. 10.3109\/00365548.2012.689847.","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"7288_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/00126334-200501010-00018","volume":"38","author":"GP Taylor","year":"2005","unstructured":"Taylor GP, Bodeus M, Courtois F, Pauli G, Del Mistro A, Machuca A, Padua E, Andersson S, Goubau P, Chieco-Bianchi L, Soriano V, Coste J, Ades AE, Weber JN: The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women. J Acquir Immune Defic Syndr. 2005, 38 (1): 104-109. 10.1097\/00126334-200501010-00018.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"14","key":"7288_CR34","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1089\/aid.1997.13.1255","volume":"13","author":"H Ellerbrok","year":"1997","unstructured":"Ellerbrok H, Fleischer C, Vandamme AM, Kucherer C, Pauli G: Sequence analysis of two HTLV type I infections imported to Germany. AIDS Res Hum Retroviruses. 1997, 13 (14): 1255-1258. 10.1089\/aid.1997.13.1255.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"7288_CR35","first-page":"47","volume-title":"Technical Report","author":"European Centre for Disease Prevention and Control","year":"2012","unstructured":"European Centre for Disease Prevention and Control: HTLV-I\/II transmission by tissue\/cell transplantation. Part 1: epidemiological review. Technical Report. 2012, Stockholm: ECDC, 47-"},{"key":"7288_CR36","volume-title":"Technical Report","author":"European Centre for Disease Prevention and Control","year":"2011","unstructured":"European Centre for Disease Prevention and Control: Evidence for the effectiveness of interventions to prevent infections among people who inject drugs; Part 1: needle and syringe programmes and other interventions for prevention hepatitis C, HIV and injecting risk behaviour. Technical Report. 2011, Stockholm: ECDC"},{"key":"7288_CR37","volume-title":"Technical Report","author":"European Centre for Disease Prevention and Control","year":"2011","unstructured":"European Centre for Disease Prevention and Control: Evidence for the effectiveness of interventions to prevent infections among people who inject drugs; Part 2: drug treatment for preventing hepatitis C, HIV and injecting risk behaviour. Technical Report. 2011, Stockholm: ECDC"},{"issue":"6\u20137","key":"7288_CR38","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1080\/10826080600669579","volume":"41","author":"A Wodak","year":"2006","unstructured":"Wodak A, Cooney A: Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence. Subst Use Misuse. 2006, 41 (6\u20137): 777-813.","journal-title":"Subst Use Misuse"},{"key":"7288_CR39","volume-title":"PreventingHIV infection among injecting drug users in high-risk countries: an assessment of the evidence","author":"H Tilson","year":"2006","unstructured":"Tilson H, Aramrattana A, Bozzette S, Celentano D, Falco M, Hammett T: PreventingHIV infection among injecting drug users in high-risk countries: an assessment of the evidence. 2006, Washington, D.C: National Academy of Sciences, Institute of Medicine"},{"issue":"8","key":"7288_CR40","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3109\/10826084.2010.540624","volume":"46","author":"U Verthein","year":"2011","unstructured":"Verthein U, Haasen C, Reimer J: Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial. Subst Use Misuse. 2011, 46 (8): 980-991. 10.3109\/10826084.2010.540624.","journal-title":"Subst Use Misuse"},{"key":"7288_CR41","volume-title":"Guidelines for Second Generation HIV Surveillance","author":"UNAIDS\/WHO Working Group on Global HIV\/AIDS and STI Surveillance","year":"2000","unstructured":"UNAIDS\/WHO Working Group on Global HIV\/AIDS and STI Surveillance: Guidelines for Second Generation HIV Surveillance. 2000, Geneva: WHO"},{"key":"7288_CR42","volume-title":"An overview of the drug-related infectious diseases (DRID) key indicator. Version, 20091","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2009","unstructured":"European Monitoring Centre for Drugs and Drug Addiction: An overview of the drug-related infectious diseases (DRID) key indicator. Version, 20091. 2009, Lisbon: EMCDDA, http:\/\/www.emcdda.europa.eu\/publications\/methods\/drid-overview ,"},{"key":"7288_CR43","unstructured":"European Monitoring Centre for Drugs and Drug Addiction and Greek REITOX Focal Point, University Mental Health Research Insitute (UMHRI): 2006, Lisbon: EMCDDA, [ http:\/\/www.emcdda.europa.eu\/html.cfm\/index65537EN.html , Protocol for the implementation of EMCDDA key indicator drug related infectios disease, Draft version October 2006."},{"key":"7288_CR44","unstructured":"Wiessing L, Bravo MJ: 2013, Lisbon: EMCDDA, DRID guidance module: behavioural indicators for people who inject drugs, Version 1.0, 2013."},{"issue":"2","key":"7288_CR45","doi-asserted-by":"publisher","first-page":"174","DOI":"10.2307\/3096941","volume":"44","author":"DD Heckathorn","year":"1997","unstructured":"Heckathorn DD: Respondent-driven sampling: a new approach to the study of hidden populations. Soc Probl. 1997, 44 (2): 174-199. 10.2307\/3096941.","journal-title":"Soc Probl"},{"issue":"Suppl 2","key":"7288_CR46","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.1097\/01.aids.0000172879.20628.e1","volume":"19","author":"R Magnani","year":"2005","unstructured":"Magnani R, Sabin K, Saidel T, Heckathorn D: Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS. 2005, 19 (Suppl 2): S67-S72.","journal-title":"AIDS"},{"issue":"1","key":"7288_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1525\/sp.2002.49.1.11","volume":"49","author":"DD Heckathorn","year":"2002","unstructured":"Heckathorn DD: Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc Probl. 2002, 49 (1): 11-34. 10.1525\/sp.2002.49.1.11.","journal-title":"Soc Probl"},{"issue":"1","key":"7288_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1024\/suc.2004.50.1.11","volume":"50","author":"L Kraus","year":"2004","unstructured":"Kraus L, Heppekausen K, Tretter F: Pr\u00e4valenzsch\u00e4tzungen von Opiatkonsumenten in deutschen Gro\u00dfst\u00e4dten: Methoden und Ergebnisse. SUCHT. 2004, 50 (1): 11-20.","journal-title":"SUCHT"},{"issue":"4","key":"7288_CR49","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/OLQ.0b013e31827fd650","volume":"40","author":"LG Johnston","year":"2013","unstructured":"Johnston LG, Prybylski D, Raymond HF, Mirzazadeh A, Manopaiboon C, McFarland W: Incorporating the service multiplier method in respondent-driven sampling surveys to estimate the size of hidden and hard-to-reach populations: case studies from around the world. Sex Transm Dis. 2013, 40 (4): 304-310. 10.1097\/OLQ.0b013e31827fd650.","journal-title":"Sex Transm Dis"},{"issue":"4","key":"7288_CR50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.drugpo.2011.05.007","volume":"22","author":"L Johnston","year":"2011","unstructured":"Johnston L, Saumtally A, Corceal S, Mahadoo I, Oodally F: High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey. Int J Drug Policy. 2011, 22 (4): 252-258. 10.1016\/j.drugpo.2011.05.007.","journal-title":"Int J Drug Policy"},{"key":"7288_CR51","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1055\/s-0028-1110008","volume":"48","author":"C Sarrazin","year":"2010","unstructured":"Sarrazin C, Berg T, Ross R, Schirmacher P, Wedemeyer H, Neumann U, Schmidt H, Spengler U, Wirth S, Kessler H: Update der S 3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-infektion. Z Gastroenterol. 2010, 48: 289-351. 10.1055\/s-0028-1110008.","journal-title":"Z Gastroenterol"},{"issue":"72","key":"7288_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1743-422X-10-72","volume":"10","author":"RS Ross","year":"2013","unstructured":"Ross RS, Stambouli O, Gruner N, Marcus U, Cai W, Zhang W, Zimmermann R, Roggendorf M: Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots-performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification. Virol J. 2013, 10 (72): 72-","journal-title":"Virol J"},{"key":"7288_CR53","volume-title":"Respondent-Driven Sampling Analysis Tool (RDSAT) Version 7.1","author":"E Volz","year":"2012","unstructured":"Volz E, Wejnert C, Cameron S, Spiller M, Barash V, Degani I, Heckathorn DD: Respondent-Driven Sampling Analysis Tool (RDSAT) Version 7.1. 2012, Ithaca, NY: Cornell University"},{"key":"7288_CR54","first-page":"61","volume-title":"MoSyD Szenestudie - Die offene Drogenszene in Frankfurt am Main","author":"M Prinzleve","year":"2004","unstructured":"Prinzleve M, M\u00fcller O, Werse B, Bernard C: MoSyD Szenestudie - Die offene Drogenszene in Frankfurt am Main. 2004, Frankfurt am Main: Centre for Drug Research (CDR), 61-"},{"issue":"6","key":"7288_CR55","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/hep.21188","volume":"43","author":"NL Toan","year":"2006","unstructured":"Toan NL, le Song H, Kremsner PG, Duy DN, Binh VQ, Koeberlein B, Kaiser S, Kandolf R, Torresi J, Bock CT: Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology. 2006, 43 (6): 1375-1384. 10.1002\/hep.21188.","journal-title":"Hepatology"},{"key":"7288_CR56","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1055\/s-0028-1110008","volume":"48","author":"C Sarrazin","year":"2010","unstructured":"Sarrazin C, Berg T, Ross RS, Schirmacher P, Wedemeyer H, Neumann U, Schmidt HHJ, Spengler U, Wirth S, Kessler HH: Update der S 3-Leitlinie Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus (HCV)-Infektion, AWMF-Register-Nr.: 021\/012 (Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften e.V.). Z Gastroenterol. 2010, 48: 289-351. 10.1055\/s-0028-1110008.","journal-title":"Z Gastroenterol"},{"key":"7288_CR57","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1055\/s-0031-1273462","volume":"49","author":"M Cornberg","year":"2011","unstructured":"Cornberg M, Protzer U, Petersen J, Wedemeyer H, Berg T, Jilg W, Erhardt A, Wirth S, Sarrazin C, Dollinger M: Aktualisierung der S 3-Leitlinie zur Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion. Z Gastroenterol. 2011, 49: 871-930. 10.1055\/s-0031-1273462.","journal-title":"Z Gastroenterol"},{"issue":"10","key":"7288_CR58","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S: MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol. 2011, 28 (10): 2731-2739. 10.1093\/molbev\/msr121.","journal-title":"Mol Biol Evol"},{"key":"7288_CR59","volume-title":"MoSyD Jahresbericht 2012 Drogentrends in Frankfurt am Main","author":"C Bernard","year":"2013","unstructured":"Bernard C, Werse B, Schell-Mack C: MoSyD Jahresbericht 2012 Drogentrends in Frankfurt am Main. 2013, Frankfurt am Main: Goethe Universit\u00e4t Frankfurt am Main, Centre For Drug Research (CDR)"},{"issue":"3","key":"7288_CR60","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.drugalcdep.2012.05.036","volume":"126","author":"HL Mills","year":"2012","unstructured":"Mills HL, Colijn C, Vickerman P, Leslie D, Hope V, Hickman M: Respondent driven sampling and community structure in a population of injecting drug users, Bristol UK. Drug Alcohol Depend. 2012, 126 (3): 324-332. 10.1016\/j.drugalcdep.2012.05.036.","journal-title":"Drug Alcohol Depend"},{"issue":"4 Suppl","key":"7288_CR61","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1007\/s10461-008-9421-1","volume":"12","author":"M Malekinejad","year":"2008","unstructured":"Malekinejad M, Johnston LG, Kendall C, Kerr LR, Rifkin MR, Rutherford GW: Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008, 12 (4 Suppl): S105-S130.","journal-title":"AIDS Behav"},{"key":"7288_CR62","volume-title":"Projekt TEST IT \u2013 Evaluationsbericht","author":"Deutsche AIDS-Hilfe e.V, AIDS-Hilfe Dortmund, Fachhochschule Dortmund","year":"2010","unstructured":"Deutsche AIDS-Hilfe e.V, AIDS-Hilfe Dortmund, Fachhochschule Dortmund: Projekt TEST IT \u2013 Evaluationsbericht. 2010, Berlin: Deutsche AIDS-Hilfe, [ http:\/\/www.aidshilfe.de\/sites\/default\/files\/_TEST_IT_Endbericht_final_0.pdf ]"},{"key":"7288_CR63","volume-title":"Infomappe f\u00fcr die Beratung in Aidshilfen 2013","author":"Deutsche AIDS-Hilfe e.V","year":"2013","unstructured":"Deutsche AIDS-Hilfe e.V: Infomappe f\u00fcr die Beratung in Aidshilfen 2013. 2013, Berlin: Deutsche AIDS-Hilfe, [ http:\/\/www.aidshilfe.de\/de\/shop\/archiv\/3862 ]"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-14-845\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-845","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-14-845.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T12:26:34Z","timestamp":1649939194000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-14-845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,14]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["7288"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-14-845","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,14]]},"assertion":[{"value":"14 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"845"}}